New drug JADE101 tested in healthy people for first time
NCT ID NCT07059312
First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 29 times
Summary
This early-stage study tests the safety of a new drug called JADE101 in 32 healthy adults aged 18 to 55. Participants receive either a single dose of JADE101 or a placebo by injection under the skin. The goal is to see how the body handles the drug and whether it causes any side effects. This study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NZCR
Auckland, New Zealand
Conditions
Explore the condition pages connected to this study.